
Ceftonox S 250mg/125mg Injection
Marketer
Kyna Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftonox S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats bacterial infections by inhibiting microbial proliferation. Administration must be under medical guidance; complete the prescribed course regardless of symptom improvement to ensure optimal efficacy. Premature cessation may compromise treatment. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote recovery. Follow-up laboratory tests may be requested to monitor treatment response.
Primary Ingredients of Ceftonox S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Ceftonox S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftonox S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ceftonox S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftonox S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Ceftonox S 250mg/125mg Injection works:
Ceftonox S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this action by neutralizing enzymes that bacteria use to resist antibiotics, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Ceftonox S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftonox S 250mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Ceftonox S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftonox S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Operation of a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftonox S 250mg/125mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Ceftonox S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Ceftonox S 250mg/125mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceftonox S 250mg/125mg Injection :
Omitting a scheduled dose of Ceftonox S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Ceftonox S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
